Mechanisms by which probiotic bacteria attenuate the risk of hepatocellular carcinoma

Keyphrases

• Hepatocellular Carcinoma 100%
• Probiotic Bacteria 100%
• Hepatocellular Carcinoma Risk 37%
• Non-alcoholic Fatty Liver Disease (NAFLD) 25%
• Nonalcoholic Steatohepatitis 25%
• B Hepatitis 25%
• Hepatitis B Virus 25%
• Risk Factors 12%
• Cirrhosis 12%
• Hepatitis C Virus Infection 12%
• Hepatitis C Virus 12%
• Chronic Infection 12%
• Obesity 12%
• Cancer Mortality 12%
• Antiproliferative Activity 12%
• Antioxidant 12%
• Single nucleotide Polymorphism 12%
• Extrinsic Risk Factor 12%
• Anticancer Activity 12%
• Risk Management 12%
• Cancer Causes 12%
• Oncogene Expression 12%
• Dietary Phytochemicals 12%
• Gut Microbiota 12%
• Hepatic Injury 12%
• Primary Liver Cancer 12%
• Antimetastatic Effect 12%
• Antiviral Activity 12%
• Tumor Suppressor Gene 12%
• Antiangiogenic 12%
• Fibrogenesis 12%
• Germline mutation 12%
• Genetic Background 12%
• Promoting Growth 12%
• Intrinsic Risk Factors 12%
• Hepatic Inflammation 12%
• Pathogen-associated Molecular Patterns 12%
• Risk Treatment 12%
• Beneficial Microbes 12%
• Dysbiosis 12%
• Alcoholic Liver Disease 12%
• Hepatocellular Carcinoma Progression 12%

Medicine and Dentistry

• Probiotic Agent 100%
• Hepatocellular Carcinoma 100%
• Nonalcoholic Fatty Liver 33%
• Hepatitis B Virus 16%
• Malignant Neoplasm 8%
• Hepatitis C 8%
• Liver Cirrhosis 8%
• Hepatitis C Virus 8%
• Infection 8%
• Liver Injury 8%
• Single Nucleotide Polymorphism 8%
• Dysbiosis 8%
• Oncogene 8%
• Phytochemical 8%
• Antioxidant 8%
• Metabolite 8%
• Liver Cancer 8%
• Pathogen Associated Molecular Pattern 8%
• Tumor Suppressor Gene 8%
• Antiviral Activity 8%
• Antiangiogenic 8%
• Germline Mutation 8%
• Fibrogenesis 8%
• Gut Microbiota 8%
• Alcohol Liver Disease 8%
• Genetic Background 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Cell Carcinoma 100%
• Probiotic Agent 100%
• Nonalcoholic Fatty Liver 33%
• Hepatitis B Virus 16%
• Malignant Neoplasm 8%
• Hepatitis C 8%
• Infection 8%
• Hepatitis C Virus 8%
• Liver Cirrhosis 8%
• Inflammation 8%
• Liver Injury 8%
• Antioxidant 8%
• Antiangiogenic 8%
• Tumor Suppressor Protein 8%
• Phytochemical 8%
• Dysbiosis 8%
• Antiviral Activity 8%
• Alcohol Liver Disease 8%
• Intestine Flora 8%
• Microorganism 8%
• Liver Cancer 8%
• Pathogen Associated Molecular Pattern 8%